Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries

Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries

Background Although current guidelines now define heart failure with midrange ejection fraction (HFmrEF) as HF with a left ventricular EF of 40% to 49%, there are limited data on response to guideline‐directed medical therapy in patients with HFmrEF. The current study aimed to evaluate the associati...

Full description

Bibliographic Details
Main Authors: Ki Hong Choi, Jin‐Oh Choi, Eun‐Seok Jeon, Ga Yeon Lee, Dong‐Ju Choi, Hae‐Young Lee, Jae‐Joong Kim, Shung Chull Chae, Sang Hong Baek, Seok‐Min Kang, Byung‐Su Yoo, Kye Hun Kim, Myeong‐Chan Cho, Hyun‐Young Park, Byung‐Hee Oh
Format: Article
Language:English
Published: Wiley 2018-11-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
aldosterone antagonist
β‐blocker
heart failure with midrange ejection fraction
medical therapy
renin‐angiotensin system blocker
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.118.009806

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.118.009806

Similar Items